Rznomics
₩21,650
0
+₩350+1.64% 06:30 Today
Statistics
Day High
21,950
Day Low
20,900
52W High
122,625
52W Low
19,990
Volume
92,449
Avg. Volume
335,858
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Rznomics Inc. develops RNA based gene therapies for cancers and intractable diseases. Its development stage product candidates include RZ-001_immune therapy combination product, which is in Phase 1b/2a stage for treating Hepatocellular carcinoma; RZ-001 (GBM) that is in Phase 1/2a stage for Glioblastoma; RZ-003, which is in discovery stage for Alzheimer; RZ-004, a pre-clinical product for Retinitis Pigmentosa; and RZ-005, a discovery stage product to treat Rett Syndrome. Rznomics Inc. was incorporated in 2017 and is headquartered in Seongnam-si, South Korea.
Show More
CEO
Mr. Seong-Wook Lee
Country
South Korea
ISIN
KR7476830005
Listings
0 Comments
Share your thoughts
FAQs
What is Rznomics stock price today?▼
The current price of 476830.KQ is ₩21,650 KRW — it has increased by +1.64% in the past 24 hours. Watch Rznomics stock price performance more closely on the chart.
What is Rznomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Rznomics stocks are traded under the ticker 476830.KQ.
In which sector is Rznomics located?▼
Rznomics operates in the Other sector.
When did Rznomics complete a stock split?▼
The last stock split for Rznomics was on June 29, 2026 with a ratio of 1:1.
Where is Rznomics headquartered?▼
Rznomics is headquartered in Seongnam-si, South Korea.